use of atropine to predict the accommodative component in esotropia with hypermetropia

Clicks: 268
ID: 176054
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This cohort study included children with esotropia and hypermetropia of ≥ +2.0 diopters (D). The deviation was measured at presentation, under atropine cycloplegia and 3 months after full refractive correction. Of 44 children with a mean age of 5.2 ± 2.4 years, 25 were males. Eighteen (41%) had fully refractive accommodative esotropia (RAE), 10 (23%) had partial accommodative esotropia (PAE), and 5 (11%) had nonaccommodative esotropia (NAE). Eleven (25%) had convergence excess (CE). Under cycloplegia, all with RAE and RAE with CE had orthotropia. There was no significant change in the deviation in the patients with NAE. The deviation under cycloplegia and that with full refractive correction in PAE and PAE with CE (with +3.0 D addition) were not different. The intraclass correlation coefficient for deviation under cycloplegia and after full refractive correction (+3.0 D addition for CE) was 0.89. It was concluded that ocular deviation under cycloplegia can help to predict the accommodative component in esotropia with hypermetropia.
Reference Key
kothari2011indianuse Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Mihir Kothari;Florence Manurung;Shalaka Paralkar
Journal Bioinformatics
Year 2011
DOI
10.4103/0301-4738.86319
URL
http://www.ijo.in/article.asp?issn=0301-4738;year=2011;volume=59;issue=6;spage=487;epage=490;aulast=Kothari
Keywords
Risk factors Screening Microbiology prism survey refractive errors risk factor diplopia myopia cataract axial length anterior chamber depth anthrax prognostic factors retinopathy of prematurity presbyopia visual impairments

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.